Abstract
The role of the endothelium, is now known to encompass the generation of many potent cytokines which impact endothelial cells, adjacent tissue such as smooth muscle cells, and distant sites in an autocrine, paracrine, and endocrine manner, respectively. This review addresses two of these cytokines, nitric oxide and endothelin, and describes how each effects the functions of endothelial cells, including regulation of platelet aggregation and coagulation, regulation of vasomotor tone, modulation of inflammation, and the regulation of cellular proliferation. The emphasis is on the increasingly recognized importance of the autocrine and paracrine mechanisms by which nitric oxide and endothelin act. In particular, autoinduction of endothelin is proposed as a central mechanism underlying endothelin's renowned effects. Additionally, specific nitric oxide/endothelin interactions are discussed by which each cytokine modulates the production and actions of the other. The net effect observed in a variety of physiological and pathophysiological settings, therefore, reflects a balance of these opposing functions.
Similar content being viewed by others
References
Engelberg H (1989) Endothelium in health and disease. Semin Thromb Hemost 15: 178–183
Kaiser L, Sparks HV Jr (1987) Endothelial cells: not just a cel-Jophane wrapper. Arch Intern Med 147: 569–573
Furchgott RF, Zawadzki JW (1980) The obligatory role of endothelial cells in the relaxation of vascular smooth muscle by acetylcholine. Nature 286: 373–376
Palmer RMJ, Ferrige AG, Moncada S (1987) Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 286: 524–526
Feelisch M, te Poel M, Zamora R, Deussen A, Moncada S (1994) Understanding the controversy over the identity of EDRF. Nature 368: 62–65
Forstermann U, Closs EI, Pollock JS, Nakane M, Schwarz P, Gath I, Kleinert H (1994) Nitric oxide synthase isozymes: characterization, purification, molecular cloning, and functions. Hypertension 23: 1121–1131
Hibbs JB Jr, Westenfelder C, Taintor R, Vavrin Z, Kablitz C, Baranowski RL, Ward JH, Menlove RL, McMurray MP, Kushner JP, Samlowski W (1992) Evidence for cytokine-inducible nitric oxide synthesis froml-arginine in patients receiving interleukin-2 therapy. J Clin Invest 89: 867–877
Nussler AK, Di Silvio M, Billiar TR, Hoffman RA, Geller DA, Selby R, Madariaga J, Simmons RL (1992) Stimulation of the nitric oxide synthase pathway in human hepatocytes by cytokines and endotoxin. J Exp Med 176: 261–264
Denis M (1991) Tumor necrosis factor and granulocyte macrophage colony-stimulating factor stimulate human macrophages to restrict growth of virulentMycobacterium avium and to kill avirulentM. avium: killing effector mechanism depends on the generation of reactive nitrogen intermediates. J Leukoc Biol 49: 380–387
Busse R, Mulsch A (1990) Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells. FEBS Lett 275: 87–90
Stuehr DJ, Cho HJ, Kwono NS, Weise MF, Nathan CF (1991) Purification and characterization of the cytokine-induced macrophage nitric oxide synthase: a FAD- and FMN-containing flavoprotein. Proc Natl Acad Sci USA 88: 7773–7777
Terada Y, Tomita K, Nonoguchi H, Marumo F (1992) Polymerase chain reaction localization of constitutive nitric oxide synthase and soluble guanylate cyclase messenger RNA's in microdissected rat nephron segments. J Clin Invest 90: 659–665
Luscher TF (1988) Endothelial vasoactive substances and cardiovascular disease. Basel, Karger
Ignarro LJ (1991) Commentary: signal, transduction mechanisms involving nitric oxide. Biochem Pharmacol 41: 485–490
Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T (1988) A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411–415
Kon V, Badr KF (1991) Biological actions and pathophysiologic significance of endothelin in the kidney. Kidney Int, 40: 1–12
Inoue, A, Yanagisawa M, Kimura S, Kasuya Y, Miyauchi T, Goto K, Masaki T (1989) The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci USA 86: 2863–2867
Marsden PA, Dorfman DM, Collins T, Brenner BM, Orkin SH, Ballermann BJ (1991) Regulated expression of endothelin-1 in glomerular capillary endothelial cells. Am J Physiol 261: F117-F125
Kohan DE, Hughes AK, Perkins SL (1992) Characterization of endothelin receptors in the inner medullary collecting duct of the rat. J Biol Chem 267: 12336–12340
Arai H, Hori S, Aramori I, Ohkubo H, Nakanishi S (1990) Cloning and expression of a cDNA encoding an endothelin receptor. Nature 348: 730–732
Sakurai T, Yanagisawa M, Takuwa Y, Miyazaki H, Kimura S, Goto K, Masaki T (1990) Cloning of a cDNA encoding a nonisopeptide-selective subtype of the endothelin receptor. Nature 348: 732–735
Terada Y, Tomita K, Nonoguchi H, Marumo F (1992) Different localization of two types of endothelin receptor mRNA in microdissected rat nephron segments using reverse transcription and polymerase chain reaction. J Clin Invest 90: 107–112
Wagner OF, Christ G, Wojta J, Vierhapper H, Parzer S, Nowotny PJ, Schneider B, Waldhausl W, Binder BR (1992) Polar secretion of endothelin-1 by cultured endothelial cells. J Biol Chem 267: 16066–16068
Mellion BE, Ignarro LJ, Ohlstein EH, Pontecorvo EG, Hyman AI, Kadowitz PJ (1981) Evidence for the inhibitory role of guanosine 3′, 5′-monophosphate in ADP-induced human platelet aggregation in the presence of nitric oxide and related vasodilators. Blood 57: 946–955
Radomski MW, Palmer RM, Moncada S (1990) Anl-arginine/nitric oxide pathway present in human platelets regulates aggregation. Proc Natl Acad Sci USA 87: 5193–5197
Penny WF, Ware JA (1992) Platelet activation and subseonent inhibition by plasmin and recombinant tissue-type plasmimogen activator. Blood 79: 91–98
Bowen R, Haslam RJ (1991) Effects of nitrovasodilators on platelet cyclic nucleotide levels in rabbit blood: role of cyclic AMP in synergistic inhibition of platelet function by SIN-1 and prostaglandin E1. J Cardiovasc Pharmacol 17: 424–433
Grodzinska L, Hafner G, Darius H (1990) Effect of molsidomine on t-PA and PAI activity in man: a double blind, placebo controlled study (letter). Thromb Haemost 64: 485
Remuzzi G, Perico N, Zoja C, Corna D, Macconi D, Vigano G (1990) Role of endothelium-derived nitric oxide in the bleeding tendency of uremia. J Clin Invest 86: 1769–1771
Noris M, Benigni A, Boccardo P, Aiello S, Gaspari F, Todeschini M, Figliuzzi M, Remuzzi G (1993) Enhanced nitric oxide synthesis in uremia: implications for platelet dysfunction and dialysis hypotension. Kidney Int 44: 445–450
Vallance P, Leone A, Calver A, Collier J, Moncada S (1992) Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 339: 572–575
Ruschitzka F, Schrader J, Luders S, Schultz E, Gronau C, Talartschik J, Eisenhauer T Verwiebe R, Wameke G, Scheler F (1993) Effects of endothelin on coagulation, prostaglandins and hemodynamics. Contrib Nephrol 101: 30–36
Halim A, Kanayama N, el Maradny E, Maehara K, Terao T (1993) Coagulation in vivo microcirculation and in vitro caused by endothelin-1. Thromb Res 72: 203–209
Yamamoto C, Kaji T, Sakamoto M, Koizumi F (1992) Effect of endothelin on the release of tissue plasminogen activator and plasminogen activator inhibitor-1 from cultured human endothelial cells and interaction with thrombin. Thromb Res 67: 619–624
Ohlstein EH, Storer BL, Butcher JA, Debouck C, Feuerstein G (1991) Platelets stimulate expression of endothelin mRNA and endothelin biosynthesis in cultured endothelial cells. Circ Res 69: 832–841
McMurdo L, Lidbury PS, Thiemermann C, Vane JR (1993) Mediation of endothelin-1 inhibition of platelet aggregation via the EtB receptor. Br J Pharmacol 109: 530–534
Cotran RS, Pober JS (1989) Effects of cytokines on vascular endothelium: their role in vascular and immune injury. Kidney Int 35: 969–975
Benigni A, Boccardo P, Noris M, Remuzzi G, Siegler RL (1992) Urinary excretion of platelet-activating factor in haemolytic uraemic syndrome. Lancet 339: 835–836
Neild GH, Brown Z (1991) Endothelium and glomerular growth. Am J Kidney Dis 27: 670–672
Flavahan NA (1992) Atherosclerosis or lipoprotein-induced endothelial dysfunction: potential mechanisms underlying reduction in EDRF/nitric oxide activity. Circulation 85: 1927–1938
Moncada S, Higgs A (1993) Thel-arginine-nitric oxide pathway. N Engl J Med 329: 2002–2012
Chen PY, St. John PL, Kirk KA, Abrahamson DR, Sanders PW (1993) Hypertensive nephrosclerosis in Dahl/Rapp rat: initial sites of injury and effect of dietaryl-arginine supplementation. Lab Invest 68: 174–184
Reyes AA, Purkerson ML, Karl I, Klahr S (1992) Dietary supplementation withl-arginine ameliorates the progression of renal disease in rats with subtotal nephrectomy. Am J Kidney Dis 20: 168–176
De Nicola L, Thomson SC, Wead LM, Brown MR, Gabbai FB (1993) Arginine feeding modifies cyclosporine nephrotoxicity in rats. J Clin Invest 92: 1859–1865
Gryglewski RJ (1993) Interactions between nitric oxide and prostacyclin. Semin Thromb Hemost 19: 158–166
Petros A, Lamb G, Leone A, Moncada S, Bennett D, Vallance P (1994) Effects of a nitric oxide synthase inhibitor in humans with septic shock. Cardiovasc Res 28: 34–39
Baylis C, Mitruka B, Deng A (1992) Chronic blockade of nitric oxide synthesis in the rat, produces systemic hypertension and glomerular damage. J Clin Invest 90: 278–281
Xu D, Emoto N, Giaid A, Slaughter C, Kaw S, deWit D, Yanagisawa M (1994) ECE-1: a membrane-bound metalloprotease that catalyzes the proteolytic activation of big endothelin-1. Cell 78: 473–485
Simonson MS, Dunn MD (1990) Endothelin: pathways of transmembrane signaling. Hypertension 15 [Suppl I]: 15–112
Pollock DA, Opgenorth TJ (1993) Evidence for endothelin-induced renal vasoconstriction independent of EtA receptor activation. Am J Physiol 264: R222-R226
Firth JD, Ratcliffe PJ (1992) Organ distribution of the three rat endothelin messenger RNA's and the effects of ischemia on renal gene expression. J Clin Invest 90: 1023–1031
Awazu M, Sugiura M, Inagami T, Ichikawa I, Kon V (1991) Cyclosporine promotes glomerular endothelin binding in vivo. J Am Soc Nephrol 1: 1253–1258
Goligorsky MS, Tsukahara H, Magazine H, Andersen TT, Malik AB, Bahou WF (1994) Termination of endothelin signaling: role of nitric oxide. J Cell Physiol 158: 485–494
Kanse S, Ghatei M, Bloom SR (1989) Endothelin binding sites in porcine aortic and rat lung membranes. Eur J Biochem 182: 175–179
Yokokawa K, Tahara H, Kohno M, Murakawa K, Yasunari K, Nakagawa K, Hamada T, Otani S, Yanagisawa M, Takeda T (1991) Hypertension associated with endothelin-secreting malignant bemangioendothelioma. Ann Intern Med 114: 213–215
Kurihara Y, Kurihara H, Suzuki H, Kodama T, Maemura K, Nagai R, Oda H, Kuwaki T, Cao W-H, Kamada N, Jishage K, Ouchi Y, Azuma S, Toyoda Y, Ishikawa T, Kumada M, Yazaki Y (1994) Elevated blood pressure and craniofacial abnormalities in mice deficient in endothelin-1. Nature 368: 703–710
Bath PM, Hassall DG, Gladwin AM, Palmer RM, Martin JF (1991) Nitric oxide and prostacyclin. Divergence of inhibitory effects on monocyte chemotaxis and adhesion to endothelium in vitro. Arteriosclerosis and Thrombosis 11: 254–260
Johnson G III, Tsao PS, Lefer AM (1991) Cardioprotective effects of authentic nitric oxide in myocardial ischemia with reperfusion. Crit Care Med 19: 244–252
Kubes P, Suzuki M, Granger DN (1991) Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 88: 4651–4655
Arndt H, Russell JB, Kurose I, Kubes P, Granger DN (1993) Mediators of leukocyte adhesion in rat mesenteric venules elicited by inhibition of nitric oxide synthesis. Gastroenterology 105: 675–680
Gryglewski RJ, Palmer RM, Moncada S (1986) Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 320: 454–456
Del Maestro RF, Planker M, Arfors KE (1982) Evidence for the participation of superoxide anion radical in altering the adhesive interaction between granulocytes and endothelium, in vivo. Int J Microcirc Clin Exp 1: 105–120
Gaboury J, Woodman RC, Granger DN, Reinhardt P, Kubes P (1993) Nitric oxide prevents leukocyte adherence: role of superoxide. Am J Physiol 265: H862–867
Mannaioni PF, Pistelli A, Gambassi F, Di Bello MG, Raspanti S, Masini E (1991) A place for free radicals in platelet-derived histamine releasing factor (PDHRF) and evidence that histaminergic receptors modulate platelet aggregation. Agents Actions 33: 57–60
Hogaboam CM, Donigi-Gale D, Shoupe TS, Bissonnette EY, Befus AD, Wallace JL (1992) Platelet-activating factor synthesis by peritoneal mast cells and its inhibition by two quinoline-based compounds. Br J Pharmacol 105: 87–92
Tonnesen MG, Anderson DC, Springer TA, Knedler A, Avdi N, Henson PM (1989) Adherence of neutrophils to cultured human microvascular endothelial cells. Stimulation by chemotactic peptides and lipid mediators and dependence upon the Mac-1, LFA-1, p150,95 glycoprotein family. J Clin Invest 83: 637–646
Jones DA, Abbassi O, McIntire LV, McEver RP, Smith CW (1993) P-selectin mediates neutrophil rolling on histamine-stimulated endothelial cells. Biophys J 65: 1560–1569
McCarron RM, Wang L, Stanimirovic DB, Spatz M (1993) Endothelin induction of adhesion molecule expression on human brain microvascular endothelial cells. Neurosci Lett 156: 31–34
Lopez Farre A, Riesco A, Espinosa G, Digiuni E, Cernadas MR, Alvarez V, Monton M, Rivas F, Gallego MJ, Egido J, Casado S, Caramelo C (1993) Effect of endothelin-1 on neutrophil adhesion to endothelial cells and perfused heart. Circulation 88: 1166–1171
Hafstrom I, Ringertz B, Lundeberg T, Palmbald J (1993) The effect of endothelin, neuropeptide Y, calcitonin gene-related peptide and substance P on neutrophil functions. Acta Physiol Scand 148: 341–346
Garg UC, Hassid A (1989) Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 83: 1774–1777
Nunokawa Y, Tanaka S (1992) Interferon-γ inhibits proliferation of rat vascular smooth muscle cells by nitric oxide generation. Biochem Biophys Res Commun 188: 409–415
Scott-Burden T, Schini VB, Elizondo E, Junquero DC, Vanhoutte PM (1992) Platelet-derived growth factor suppresses and fibroblast growth factor enhances cytokine-induced production of nitric oxide in cultured smooth muscle cells. Effects on cell proliferation. Circ Res 71: 1088–1100
Junquero DC, Scott-Burden T, Schini VB, Vanhoutte PM (1992) Inhibition of cytokine-induced nitric oxide production by transforming growth factor-β1 in human smooth muscle cells. J Physiol 454: 451–465
Taguchi J, Abe J, Okazaki H, Takuwa Y, Kurokawa K (1993)l-Arginine inhibits neointimal formation following balloon injury. Life Sci 53: 387–392
Weiner CP, Lizasoain I, Baylis S, Knowles RG, Charles IG, Moncada S (1994) Induction of calcium-dependent nitric oxide syntheses by sex hormones. Proc Natl Acad Sci USA 91: 5212–5216
Ito H, Hirata Y, Hiroe M, Tsujino M, Adachi S, Takamoto T, Nitta M, Taniguchi K, Marumo F (1991) Endothelin-1, induces hypertrophy with enhanced expression of muscle-specific genes in cultured neonatal rat cardiomyocytes. Circ Res 69: 209–215
Battistini B, Chailler P, D'Orleans-Juste P, Briere N, Sirois P (1993) Growth regulatory properties of endothelins. Peptides 14: 3855–399
Perico N, Remuzzi G (1993) Role of endothelin in glomerular injury. Kidney Int 43 [Suppl 39]: S76-S80
Simonson MS, Wann S, Mene P, Dubyak GR, Kester M, Nakazato Y, Sedor JR, Dunn MJ (1989) Endothelin stimulates phospholiphase C, Na/H exchange, c-fos expression, and mitogenesis in rat mesangial cells. J Clin Invest 83: 708–712
Ishimura E, Shouji S, Nishizawa Y, Morii H, Kashgarian M (1991) Regulation of mRNA expression for extracellular matrix (ECM) by cultured rat mesangial cells (MCS) (abstract). J Am Soc Nephrol 2: 546
Guarda E, Katwa LC, Myers PR, Tyagi SC, Weber KT (1993) Effects of endothelins on collagen turnover in cardiac fibroblasts. Cardiovasc Res 27: 2130–2134
Bunchman TE, Brookshire CA (1991) Cyclosporine-induced synthesis of endothelin by cultured human endothelial cells. J Clin Invest 88: 310–314
Benigni A, Zoja C, Corna D, Orisio S, Longaretti L, Bertani T, Remuzzi G (1993) A specific endothelin subtype A receptor antagonist protects against injury in renal disease progression. Kidney Int 44: 440–444
Hunley TE, Fogo A, Iwasaki S, Kon V (1994) Endothelin A receptor mediates functional but not structural damage in chronic cyclosporine nephrotoxicity (abstract). J Am Soc Nephrol 5: 181
Kon V, Fogo A (1994) Endothelin mediates vasoconstriction whereas angiotensin II is linked to interstitial fibrosis in chronic cyclosporine toxicity (abstract). J Am Soc Nephrol 5: 924
Casscells W (1992) Migration of smooth muscle and endothelial cells: critical events in restenosis. Circulation 86: 723–729
Morigi M, Zoja C, Figliuzzi M, Remuzzi G, Remuzzi A (1993) Supernatant of endothelial cells exposed to laminar flow inhibits mesangial cell proliferation. Am J Physiol 264: C1080-C1083
Yoshizumi M, Kurihara H, Sugiyama T, Takaku F, Yanagisawa M, Masaki T, Yazaki Y (1989) Hemodynamic shear stress stimulates endothelin production by cultured endothelial cells. Biochem Biophys Res Commun 161: 859–864
Kuchan MJ, Frangos JA (1993) Shear stress regulates endothelin-1 release via protein kinase C and cGMP in cultured endothelial cell. Am J Physiol 264: H150-H156
Malek AM, Greene AL, Izumo S (1993) Regulation of endothelin 1 gene by fluid shear stress is transcriptionally mediated and independent of protein kinase C and cAMP. Proc Natl Acad Sci USA 90: 5999–6003
Warner TD, de Nucci G, Vane JR (1989) Endothelin is a vasodilator in the isolated perfused mesentery of the rat. Eur J Pharmacol 159: 325–326
Hirata Y, Emori T, Eguchi S, Kanno K, Imai T, Ohta K, Marumo F (1993) Endothelin receptor subtype B mediates synthesis of nitric oxide by cultured bovine endothelial cells. J Clin Invest 91: 1367–1373
Kohan DE, Padilla E (1994) Endothelin-1 production by rat inner medullary collecting duct: effect of nitric oxide, cGMP, and immune cytokines. Am J Physiol 266: F291-F297
Boulanger C, Luscher TF (1990) Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide. J Clin Invest 85: 587–590
Iwasaki S, Homma T, Kon V (1994) Endothelin B receptor (EtB) mediates auto-induction of endothelin-1 (Et-1) (abstract). J Am Soc Nephrol 5: 717
Coffey RJ Jr, Derynck R, Wilcox JN, Bringman TS, Goustin AS, Moses HL, Pittelkow MR (1987) Production and auto-induction of transforming growth factor-α in human keratinocytes. Nature 328: 817–820
Border WA, Noble NA (1993) Cytokines in kidney disease: the role of transforming growth factor-β. Am J Kidney Dis 22: 105–113
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hunley, T.E., Iwasaki, S., Homma, T. et al. Nitric oxide and endothelin in pathophysiological settings. Pediatr Nephrol 9, 235–244 (1995). https://doi.org/10.1007/BF00860758
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00860758